These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9617767)

  • 21. Characteristic in vitro evolution pattern of foot and mouth disease virus A81/Castellanos/Arg/87.
    Mbayed V; Schiappacassi M; Corominas A; Campos R
    Virus Res; 1997 May; 48(2):157-63. PubMed ID: 9175254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
    Kit M; Kit S; Little SP; Di Marchi RD; Gale C
    Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona.
    Gomes P; Giralt E; Andreu D
    Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site.
    Feigelstock D; Mateu MG; Piccone ME; De Simone F; Brocchi E; Domingo E; Palma EL
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3307-11. PubMed ID: 1335031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs.
    Sanz-Parra A; Jimenez-Clavero MA; García-Briones MM; Blanco E; Sobrino F; Ley V
    Virology; 1999 Jun; 259(1):129-34. PubMed ID: 10364496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
    Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of foot-and-mouth disease virus C3 Resende to immunological pressure exerted in vitro by antiviral polyclonal sera.
    Schiappacassi M; Rieder Rojas E; Carrillo E; Campos R
    Virus Res; 1995 Apr; 36(1):77-85. PubMed ID: 7542827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype.
    Hernández J; Martínez MA; Rocha E; Domingo E; Mateu MG
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():213-6. PubMed ID: 1370534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
    Lea S; Abu-Ghazaleh R; Blakemore W; Curry S; Fry E; Jackson T; King A; Logan D; Newman J; Stuart D
    Structure; 1995 Jun; 3(6):571-80. PubMed ID: 8590018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
    Diez J; Mateu MG; Domingo E
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure.
    Haydon D; Lea S; Fry L; Knowles N; Samuel AR; Stuart D; Woolhouse ME
    J Mol Evol; 1998 Apr; 46(4):465-75. PubMed ID: 9541542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.
    Reynolds C; Birnby D; Chow M
    J Virol; 1992 Mar; 66(3):1641-8. PubMed ID: 1310770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
    Pfaff E; Thiel HJ; Beck E; Strohmaier K; Schaller H
    J Virol; 1988 Jun; 62(6):2033-40. PubMed ID: 2835507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.
    Lewis SA; Morgan DO; Grubman MJ
    J Virol; 1991 Dec; 65(12):6572-80. PubMed ID: 1658362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two mechanisms of antigenic diversification of foot-and-mouth disease virus.
    Martínez MA; Hernández J; Piccone ME; Palma EL; Domingo E; Knowles N; Mateu MG
    Virology; 1991 Oct; 184(2):695-706. PubMed ID: 1653494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants.
    Sanyal A; Venkataramanan R; Pattnaik B
    Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.